VELOXIS PHARMACEUTICALS
LIVE

Serial Number

79101875

Owner

VELOXIS PHARMACEUTICALS A/S

Attorney

Julia Anne Matheson

Filing Date

Jul 7, 2011

Add to watchlist:

No watchlists yet
View on USPTO

VELOXIS PHARMACEUTICALS Trademark

Serial Number: 79101875 • Registration: 4348454

VELOXIS PHARMACEUTICALS is a trademark filed by VELOXIS PHARMACEUTICALS A/S on July 7, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Veloxis Pharmaceuticals, Inc. (13 trademarks)

2000 Regency Parkway,

Entity Type: 99

Trademark Details

Filing Date

July 7, 2011

Registration Date

June 11, 2013

Published for Opposition

March 26, 2013

Goods & Services

Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields

[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified drug delivery release systems, and pharmaceutical controlled drug delivery release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of mental and physical disorders, emergencies and traumas, aging, namely, Alzheimer's disease, arthritis, shock, immune system diseases, allergies and burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary disorders, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, gynecological diseases, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, psychiatric diseases and disorders, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain

[ Consulting in the field of intellectual property licensing; licensing of intellectual property ]

Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical consultation, pharmaceutical advice, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Feb 5, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 9, 2024 INPS
INVALIDATION PROCESSED
Jan 9, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 30, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 31, 2023 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 31, 2023 71.P
TEAS SECTION 71 RECEIVED
Mar 30, 2023 ES71
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 21, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 21, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 21, 2023 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 11, 2022 REM4
CHANGE OF OWNER RECEIVED FROM IB
Sep 18, 2021 CHLD
INTERNATIONAL REGISTRATION RENEWED
Jul 22, 2021 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 21, 2021 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2020 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 20, 2019 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 1, 2019 INPS
INVALIDATION PROCESSED
Nov 1, 2019 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 13, 2019 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 13, 2019 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 13, 2019 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 12, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 6, 2019 ES75
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sep 17, 2018 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 3, 2018 CRCV
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 11, 2018 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 18, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jul 21, 2016 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 26, 2015 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 11, 2014 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 7, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2013 FICS
FINAL DISPOSITION PROCESSED
Sep 13, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 11, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2013 R.PR
NOTIFICATION PROCESSED BY IB
May 6, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2013 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 6, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 19, 2013 PREV
EXPARTE APPEAL TERMINATED
Feb 11, 2013 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 11, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2013 CNEA
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jan 23, 2013 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jan 23, 2013 GECD
ACTION CONTINUING FINAL - COMPLETED
Jan 23, 2013 CNCF
EX PARTE APPEAL-INSTITUTED
Jan 2, 2013 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 2, 2013 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 2, 2013 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 17, 2012 ERFR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 15, 2012 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 14, 2012 CRCV
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 2, 2012 GNFN
FINAL REFUSAL E-MAILED
Jul 2, 2012 GNFR
FINAL REFUSAL WRITTEN
Jul 2, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2012 CRFA
ASSIGNED TO LIE
May 22, 2012 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2012 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 10, 2012 TROA
REFUSAL PROCESSED BY IB
Dec 18, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 10, 2011 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 4, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 3, 2011 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 23, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2011 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 16, 2011 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 15, 2011 REPR